The specifics will vary, but generally, you will undergo initial screening to assess eligibility, followed by regular clinic visits throughout the trial duration. These visits may involve examinations, tests, and receiving the study intervention.
Active Psoriatic arthritis clinical trials, where your involvement will contribute to better health outcomes.
Most people with active psoriatic arthritis have psoriasis, a chronic autoimmune skin condition. Psoriatic arthritis (PsA) is an inflammatory arthritis that affects some individuals with psoriasis. While not everyone with psoriasis develops psoriatic arthritis, it’s estimated that up to 30% of people with psoriasis may eventually develop this condition.
We’re conducting active psoriatic arthritis clinical trials to evaluate the efficacy and safety of an investigational drug versus a placebo.
*Participation in the Clinical Trial is completely free of cost and is your choice.
*To participate, fill out the form, and someone from our research staff will call you to determine your eligibility for the Clinical Research Study.
After agreeing to participate in the study, you’ll be requested to sign an Informed Consent Form, which outlines all study details. The study team will also guide you through the trial process and your role within it. We strongly encourage participants to ask any questions they may have before committing to participation. Ultimately, the decision to join or withdraw from the trial rests entirely with you.
Once the consent form is signed and all queries are addressed, participants are randomly assigned to one of two groups in the psoriatic arthritis study:
Control group: Receives a placebo medication lacking the active ingredient.
Experimental group: Receives the actual study drug containing active ingredients.
As the research follows a double-blind design, neither the researcher nor the participant knows which treatment or intervention they’re receiving.
*All study procedures and study-related treatment, including the investigational drug, are free of cost, and insurance is not required to participate.
*The study doctor will take you through every step of the Clinical Trial before you decide to participate and will answer any questions you have about the study treatment.
If you have psoriatic arthritis and are interested in participating in a research study, please complete the above form. A research team member will contact you to discuss your potential eligibility for the study. If you are deemed eligible, you may be invited to visit the nearest research site for further screening.
You’ll be asked to review and sign an Informed Consent Form as part of the screening process. Before signing, the study doctor will provide a comprehensive explanation of the study, including details about the psoriasis treatment being investigated, potential risks and benefits, and expectations for study visits. We encourage all participants to ask questions and ensure they fully understand the information provided before signing the form.
*Study-related care is offered at no charge. Expert physicians and healthcare professionals conduct thorough physical exams and assessments.*
18 years and older adults
Male & Female
Psoriatic Arthritis
Recruiting
Psoriatic arthritis (PsA) is a chronic inflammatory arthritis that affects people with psoriasis, a skin condition characterized by red, scaly patches. While psoriasis itself isn’t contagious, PsA can significantly impact joints and overall well-being.
The specifics will vary, but generally, you will undergo initial screening to assess eligibility, followed by regular clinic visits throughout the trial duration. These visits may involve examinations, tests, and receiving the study intervention.
Every clinical trial has potential risks and benefits. You will be provided with detailed information about the study you’re considering, including potential side effects and benefits.
Eligibility criteria vary depending on the specific trial. Factors like age, severity of PsA, current medications, and overall health may be considered.